Navigation Links
Assessing the Competition in Rare Disease Clinical Trials: The Need for a Thorough Feasibility Strategy, Upcoming Webinar Hosted by Xtalks
Date:2/21/2020

In a free session on Tuesday, March 10, 2020 at 11am EDT (3pm GMT/UK) join guest speakers from Synteract including Lisa Dilworth, BS, MS, Vice President Rare, Orphan and Pediatric Diseases, and Rachael Young, Associate Director, Feasibility for a discussion about these challenges, with feasible strategies and solutions to support patients, sites and sponsors.

When planning a rare disease clinical trial, drug developers can expect to face several challenges. In many cases, developers approach the study believing that patient recruitment will be their biggest obstacle. They are correct in making this assumption, but it is not always for the reasons they assumed.

Finding patients is, in fact, the most common obstacle experienced in rare disease clinical trials. Nevertheless, it is not always due to lack of patient presence, rather it is the culmination of several key challenges. This includes but is not limited to understanding the diagnostic odyssey, competitive study and treatment landscape, ability to operationalize at the global, regional and site level. This is where a robust, data-driven feasibility analysis becomes a necessary, key component.

For more information or to register for this event, visit Assessing the Competition in Rare Disease Clinical Trials: The Need for a Thorough Feasibility Strategy.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Read the full story at https://www.prweb.com/releases/assessing_the_competition_in_rare_disease_clinical_trials_the_need_for_a_thorough_feasibility_strategy_upcoming_webinar_hosted_by_xtalks/prweb16922730.htm.


'/>"/>
Source: PRWeb
Copyright©2020 Vocus, Inc.
All rights reserved


Related biology technology :

1. Transparency Life Sciences Announces Start Of Ulcerative Colitis Clinical Trial Assessing Feasibility Of Decentralized Patient Data Collection
2. Results of new exploratory analyses assessing the incidence of hypoglycemia with linagliptin in adults with type 2 diabetes announced
3. Specialty Reprocessor Moves Ahead of Competition to Offer More Savings in the Electrophysiology Lab
4. MyBioGate Global Healthcare Innovation Competition Boston Preliminary Successfully Came to the Conclusion
5. Medable Wins DPharm Idol Competition for Human Digitome as a Disruptive Application in Clinical Research
6. The Refinery Launches 2nd Annual “Fueling the Growth” Competition
7. Matrix IT Wins AIM 2017 AIDC Case Study Competition
8. CTNext Awards $44,000 to Connecticut Companies at 12th Entrepreneur Innovation Awards Competition in Stamford
9. Greater SA Chamber of Commerce Teams Up with South Texas Blood & Tissue Center for the SA Business Challenge competition
10. The Institute for Venture Science Announces Solicitation for Pre-Proposals for Scientific Competition
11. Students Present Big Ideas, Compete for $60,000, Win Bigger at 14th Annual WSU Business Plan Competition
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/19/2020)... ... February 18, 2020 , ... Intech ... launch of a new and unified global brand identity, as it celebrates its ... engineering challenges, as well as an enthusiasm for designing and manufacturing state-of-the-art medical ...
(Date:2/13/2020)... ... , ... Arriello , a provider of market access, ... Safety™ as part of the company’s continued growth in pharmacovigilance operations. , ... information such as SUSARs and ICSRS, aggregate report production, signal management, and management ...
(Date:2/11/2020)... ... February 11, 2020 , ... Synagro ... North America, today announced that the City of Fort Worth has partnered with ... needs. Commencing in April of 2020, Synagro will assume operation of the city’s ...
(Date:2/5/2020)... ... 04, 2020 , ... Shoreline Biome , a microbiome ... level, has announced a new distribution partnership in Asia. , The distribution partner, ... companies and research organizations in China, Hong Kong, and Macau. , Gene Company ...
Breaking Biology Technology:
(Date:3/2/2020)... (PRWEB) , ... March 02, 2020 , ... Toronto-based clinical ... is soon opening its newest office location just 5 minutes south of Clarksburg on ... orchard on the property, called End of the Rainbow Orchard, and decided it would ...
(Date:2/28/2020)... ... ... Meridian Clinical Research , a leading investigative research network, is a finalist ... Trial Site. Meridian is also the largest member of Platinum Research Network , ... the result of two voting rounds, and winners will be announced at the World ...
(Date:2/28/2020)... ... February 27, 2020 , ... ... formed Filtravate, its newest portfolio company. Established to develop and commercialize a ... licensed from New Mexico State University (NMSU). The patent-pending technology results in ...
Breaking Biology News(10 mins):